Company / R&D per Share
Eloxx Pharmaceuticals, Inc. R&D per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$2.74
FY2025
5-year range
$0.15 / $2.74
FY2021-FY2025
Trend
+1436.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share changed +1436% YoY in FY2025, a notable deviation from the 3-year average annual change of +456%.
Based on SEC 10-K filings.
2.74 in FY2025 with a 10-year CAGR of +33.6%.
Improved from $0.15 to $2.74 over the past 10 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +33.6%
Key checks
Key Insights
- In FY2025, r&d per share increased 1436.3% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -40.59 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.74 | +1436.3% |
| FY2016 | $0.18 | +18.1% |
| FY2015 | $0.15 | -86.7% |
| FY2014 | $1.13 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026